EMZERCO Trademark

Trademark Overview

On Wednesday, February 20, 2013, a trademark application was filed for EMZERCO with the United States Patent and Trademark Office. The USPTO has given the EMZERCO trademark a serial number of 85854573. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 5, 2016. This trademark is owned by Millennium Pharmaceuticals, Inc.. The EMZERCO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer
emzerco

General Information

Serial Number85854573
Word MarkEMZERCO
Filing DateWednesday, February 20, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 5, 2016
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 4, 2013

Trademark Statements

Goods and ServicesPharmaceutical preparations for human use, namely, for the treatment of hematological malignancies, cancer, auto-immune diseases and disorders and inflammatory diseases and disorders; pharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 27, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameMillennium Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139
Party NameMillennium Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2016ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 5, 2016ABANDONMENT - NO USE STATEMENT FILED
Thursday, January 21, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 20, 2016EXTENSION 5 GRANTED
Tuesday, January 5, 2016EXTENSION 5 FILED
Tuesday, January 5, 2016TEAS EXTENSION RECEIVED
Tuesday, July 14, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 13, 2015EXTENSION 4 GRANTED
Monday, July 6, 2015EXTENSION 4 FILED
Monday, July 6, 2015TEAS EXTENSION RECEIVED
Saturday, January 17, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 16, 2015EXTENSION 3 GRANTED
Monday, January 12, 2015EXTENSION 3 FILED
Monday, January 12, 2015TEAS EXTENSION RECEIVED
Saturday, August 9, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 8, 2014EXTENSION 2 GRANTED
Tuesday, July 15, 2014EXTENSION 2 FILED
Friday, August 8, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 15, 2014TEAS EXTENSION RECEIVED
Friday, January 10, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 8, 2014EXTENSION 1 GRANTED
Wednesday, January 8, 2014EXTENSION 1 FILED
Wednesday, January 8, 2014TEAS EXTENSION RECEIVED
Wednesday, January 8, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, July 30, 2013NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 4, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 15, 2013NOTICE OF PUBLICATION
Tuesday, April 30, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 29, 2013ASSIGNED TO EXAMINER
Wednesday, February 27, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Sunday, February 24, 2013NEW APPLICATION ENTERED IN TRAM

Related Keywords

emzerco diseases pharmaceutical cancer treatment disorders preparations inflammatory immune malignancies human